Research in Drug Development (RD3)

Pharmacognosy Bioanalysis and Drug Discovery

Contact
 

Research activities

His research aims to clarify the role of genetic risk and environmental factors implicated  diabetes and identify the tissue-specific molecular mechanisms and pathways.  In this context, he uses computational and bioinformatics approaches to multi-omics datasets in order to fine map the diabetes associated variants and link them to their functional effect. He also uses multi-tissue datasets to identify the specific tissues in which these variants exert their effect. In addition, he has developed several novel bioinformatics methods to advance this field of research.

Top ten recent articles

En attente des données.
Rafraîchir.